Financhill
Back

Telomir Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41

TELO
Telomir Pharmaceuticals, Inc.

Last Price:
$1.28
Seasonality Move:
-24.18%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is relatively stagnant and TELO is experiencing slight selling pressure.

Telomir Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.27 Buy
20-day SMA: 1.3 Sell
50-day SMA: 1.25 Buy
200-day SMA: 1.42 Sell
8-day EMA: 1.28 Sell
20-day EMA: 1.28 Sell
50-day EMA: 1.29 Sell
200-day EMA: 1.71 Sell

Telomir Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 49.23 Sell
Chaikin Money Flow: -43660 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.25 - 1.35) Sell
Bollinger Bands (100): (1.21 - 1.41) Sell

Telomir Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Telomir Pharmaceuticals, Inc. Stock

Is Telomir Pharmaceuticals, Inc. Stock a Buy?

TELO Technical Analysis vs Fundamental Analysis

Sell
41
Telomir Pharmaceuticals, Inc. (TELO) is a Sell

Is Telomir Pharmaceuticals, Inc. a Buy or a Sell?

Telomir Pharmaceuticals, Inc. Stock Info

Market Cap:
42.2M
Price in USD:
1.27
Share Volume:
87.3K

Telomir Pharmaceuticals, Inc. 52-Week Range

52-Week High:
3.23
52-Week Low:
1.05
Sell
41
Telomir Pharmaceuticals, Inc. (TELO) is a Sell

Telomir Pharmaceuticals, Inc. Share Price Forecast

Is Telomir Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Telomir Pharmaceuticals, Inc.

Is Telomir Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Telomir Pharmaceuticals, Inc.

Should I short Telomir Pharmaceuticals, Inc. stock?

* Telomir Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.